Immunotherapy for Head and Neck Cancer Treatment
1 Vues
• 07/02/23
0
0
Intégrer
administrator
Les abonnés
Head and neck cancer and skull base surgeon Nyall London discusses immunotherapy clinical trials that have contributed to FDA approval for nivolumab and pembrolizumab for recurrent head and neck squamous cell carcinoma. https://hopkinsmedicine.org/oto #HeadandNeckCancerTreatment #JohnsHopkins
Montre plus
Commentaires de Facebook
SORT BY-
Meilleures Commentaires
-
Derniers Commentaires